Exploring U.S. and International Revenue Exposures in Dividend Stocks

This chapter explores recent shifts in revenue exposure for dividend-paying stocks, focusing on companies like Texas Instruments and Pfizer. It analyzes the implications of revenue diversification on investment strategies and compares market performance trends between U.S. and international stocks.

Transcript

chevron_right

Play full episode

chevron_right

Transcript

Episode notes

The revenue of US dividend stocks isn’t necessarily made in America. A portfolio of popular dividend-paying stocks is likely exposed to currency or geopolitical risks. That’s due to international revenue exposure: Some US-based companies earn 50% or more of their money outside of the country. A recent analysis of 35 dividend-paying stocks in Morningstar’s DividendInvestor newsletter found several well-known names generate sizable revenue overseas. So, how should investors balance US vs. non-US equity exposure? Morningstar’s DividendInvestor newsletter editor David Harrell explains what investors should know.

Learn about Morningstar’s new Medalist Ratings for semiliquid funds during a live webinar on Morningstar’s YouTube channel on Wednesday, September 10th. CEO Kunal Kapoor and Global Head of Manager Research Laura Lutton will discuss what investors should know about private assets and the first funds to earn the new rating on the Investors First series.

On this episode:

You recently analyzed the international revenue exposure of dozens of dividend-paying stocks. But this wasn’t the first time. Why did you decide to revisit this?

Let’s dissect the investigation. How did you choose which stocks to focus on, and what was the criteria?

How did the recent results compare to the findings in 2021? Were there any surprises?

Let’s zoom in on the revenue. Which dividend stocks increased or decreased their US revenue exposure?

Morningstar analysts consider some of these dividend payers undervalued. Let’s first focus on names with more US revenue exposure. Who are they?

Which companies with more international revenue exposure are undervalued?

International stocks are having a long-awaited banner year versus US stocks. Are investors whose only international revenue exposure is these US-based stocks benefiting from this international rally?

How should investors balance US vs. non-US equity exposure in their portfolios? That is, what if investors looking at their portfolio see that they have home-country bias? What should they consider from a diversification standpoint?

Welcome to Investing Insights, Kunal. Let’s get started with you telling the audience a bit about your career here at Morningstar. It started back in the late 90s, right?

Your series, Investors First, is airing live on YouTube for the first time on September 10th. Can you tell us about the mission behind it? What are you hoping to achieve with the series?

It’s important to have these conversations with investors. What can Morningstar do to further empower them?

Investors have experienced a lot of short-term volatility this year. How do folks stay focused on their long-term goals?

Read about topics from this episode.

Subscribe to Morningstar’s DividendInvestor newsletter.

Why 2025 Is the Year to Invest in International Stocks

Why It’s Not Too Late to Add International Exposure

What Investors Can Learn from Dow’s 50% Dividend Cut

Where to Find Bargain Stocks in an Expensive Market

Watch more from the Investors First series:

Investors First: Evolving Expectations and Expanding Access

Where Should Investors Look Next Among Economic Mixed Messages?

Investors First: Navigating the Rise of Active ETFs in a Competitive Market